The global pharmaceutical contract packaging market is projected to increase from USD 17.06 billion in 2024 to approximately USD 43.46 billion by 2034, expanding at a CAGR of 9.8% between 2024 and 2034.
Stevanato Group S.p.A. (NYSE: STVN), SCHOTT Pharma AG & Co. KGaA (MDAX: 1SXP), and Gerresheimer AG, a cutting-edge system and solution provider and a global partner for the pharmaceutical, biotech, and cosmetic industries, announced today that they have formed a strategic industry alliance ("Alliance for RTU") to promote the market adoption of Ready-to-Use (RT) vials and cartridges. By emphasizing the benefits of RT designs over traditional bulk packaging, the Alliance for RTU seeks to impart technical knowledge and skills in high-quality sterile primary packaging, particularly ready-to-fill vials and cartridges, to pharmaceutical companies, CMOs, and CDMOs.
Lukas Burkhardt, a member of Gerresheimer AG's (Gerresheimer AG -primary packaging products for medication and drug delivery devices company) management board, stated that as an industry, the company is fully prepared for the transition to RT vials and cartridges. With recent advancements, RT processing is a mature technology which will improve our customers’ operations in terms of efficiency, cost and time to market. Franco Stevanato, CEO of Stevanato Group stated that the quality of products has significantly improved due to RT vials and cartridges, which provide increased dependability and efficiency in pharmaceutical procedures. This partnership enables the company to further emphasize how RT solutions raise industry standards, guaranteeing patients throughout the world receive their prescriptions in a safer and more efficient manner.
Andreas Reisse, CEO of SCHOTT Pharma stated that the shift towards ready-to-use cartridges and vials reflects a collective industry shift to advance efficiency and quality in aseptic filling processes and this alliance shows readiness by increasing capacity and thereby supporting the market trend. Ready-to-use solutions can reduce complexities and better meet the stringent requirements of modern pharmaceutical production. At a special event held at the exposition fairground on October 8, 2024, the Alliance for RT will be formally introduced at the PHI in Milan.